Fuad El-Hibri, Chairman at Emergent BioSolutions Inc. (EBS), sold 60,000 shares at $100.68 ($6.1M) on 2020-09-17, disclosed to the SEC on 2020-09-18.
Open-market sale of $6.1M EBS by Chairman. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $102.48 | 20,000 | $2.0M | 33.7% |
| 2 | $100.68 | 20,000 | $2.0M | 33.1% |
| 3 | $100.68 | 20,000 | $2.0M | 33.1% |
| Total | $101.28 avg | 60,000 | $6.1M | 100% |
| Filing → |
| EBS | SELL | 2020-09-25 | $3.8M | — | Filing → |
| EBS | SELL | 2020-09-11 | $4.1M | — | Filing → |
| EBS | SELL | 2020-05-01 | $3.0M | — | Filing → |